Houses
of Artemisia
Houses of Artemisia are local multidisciplinary centres of expertise responsible for overseeing the sustainable cultivation and spread of the plant in malaria-endemic countries.
There are currently 91 Houses of Artemisia in 24 countries.
Artemisia
We use the generic term “Artemisia” to refer to Artemisia afra and Artemisia annua plants that we are studying in the fight against malaria and bilharzia.
« Traditional Medicine, of proven quality, safety, and efficacy, contributes to the goal of ensuring that all people have access to care » and « will help health care leaders to develop solutions that contribute to a broader vision of improved health and patient autonomy»
WHO Traditional Medicine Strategy 2014-2023
Medical and legal perspectives
Artemisia annua and afra infusions have been used for centuries in China and Africa to treat parasitic diseases.
We are committed to accelerating their recognition in the provision of care for the most deprived populations.
La Maison de l’Artemisia association strongly advises against the use of Artemisia herbal tea for all travellers from countries where malaria is not endemic and who have access to medication currently recommended by the WHO.
Association life
10 Dec 2020Artemisia: the anti malaria! Our new donation campaign- 08 Oct 2020Artemisia annua, possible treatment against Covid-19 : Status report on research
- 20 Jul 2020Urgent call for test on Artemisia for Covid-19 treatment
- 20 Jul 2020Artemisia communication campaign in Benin
- 20 Jul 2020A new partner by our side!
- 20 Jul 2020Launch of National Association of Houses of Artemisia in Burkina Faso
Talking points
- Study reveals potential utility of artemisinin-based treatments against SARS-CoV-206 Oct 2020
- Mexico City selects patients for COVID-19 treatment trials29 Sep 2020
- Cech lab receives funding to study how plant medicines can treat disease18 Sep 2020
- Coronavirus: What do we know about the Artemisia plant?10 Sep 2020
- Traditional medicine receives global recognition28 Aug 2020
- Cancer, COVID and the Kentucky Economy: How “Sweet Annie” Could Make an Impact12 Aug 2020
🌿Et nous remettons pour la 3ème fois cette étude en preprint qui est systématiquement retirée par FB ! 😢 https://www.biorxiv.org/content/10.1101/2021.01.08.425825v1?fbclid=IwAR0S8hJWwibU2q1t56p9mfIv9SZXBXmIFiSMONdUDH0k13ewbSUFOgMAxI8
www.biorxiv.org
Artemisia annua L. extracts prevent in vitro replication of SARS-CoV-2
SARS-CoV-2 (Covid-19) globally has infected and killed millions of people. Besides remdesivir, there are no approved small molecule-based therapeutics. Here we show that extracts of the medicinal plant, Artemisia annua L., which produces the antimalarial drug artemisinin, prevents SARS-CoV-2 replica...
Bravo aux chercheurs ! 👏🏻👏🏻👏🏻🌿🌿🌿 https://www.news-medical.net/news/20210111/Extract-of-medicinal-plant-Artemisia-annua-interferes-with-replication-of-SARS-CoV-2-in-vitro.aspx
www.news-medical.net
Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro
Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
Your stories
Treatment with Artemisia is radically changing the daily lives of many people around the world. This success comes thanks to the commitment of hundreds of people working in different sectors around the globe to put an end to malaria !
The agronomist in Musigati in Bubanza province, Burundi, swears by Artemisia. He was very ill and now he no longer has malaria.
